SNDX SYNDAX PHARMACEUTICALS INC Investments/Divestments 8-K Filing 2023 - Agreement for Stock Issuance Syndax Pharmaceuticals entered into an underwriting agreement with Goldman Sachs, J.P. Morgan, and Cowen for the issuance and sale of 10,810,810 shares of common stock, expected to raise approximately $200 million.Get access to all SEC 8-K filings of the SYNDAX PHARMACEUTICALS INC